Trimetazidine

Dihydrochloride

Stable angina pectoris (chest pain)

Variant angina (Prinzmetal's angina)

Taziquid 20 Tablet (Trimetazidine) inhibits the long-chain 3-ketoacyl-CoA thiolase enzyme, which is involved in fatty acid oxidation in the heart. By reducing fatty acid oxidation, it promotes glucose oxidation as an alternative energy source for the heart, thus improving myocardial energy metabolism and reducing ischemia (lack of blood flow) in the heart muscle.

Store below 25°C in a dry place, protected from light and moisture. Keep out of reach of children.

The dosage and frequency of administration should always be prescribed by a healthcare professional.

Typical starting dose is 35 mg twice daily.

The dose may be increased to 70 mg twice daily if needed by a physician.

Take the medication with food or milk to reduce stomach upset.

Do not stop taking the medication suddenly without consulting your doctor.

Nausea

Vomiting

Diarrhea

Constipation

Abdominal pain

Dizziness

Headache

Fatigue

Insomnia

Dyspnea (shortness of breath)

Alcohol Consumption

Alcohol may increase the risk of dizziness and drowsiness. Limit or avoid alcohol while taking trimetazidine.



While Driving or operating Machinery

Trimetazidine can cause dizziness, so avoid driving or operating machinery if experiencing these side effects.



Pregnant & Breastfeeding Women

Use during pregnancy and breastfeeding should be strictly as per doctor's advice; benefits should outweigh risks. Further research is needed on safety during pregnancy and breastfeeding.



Children

Safety and efficacy in children have not been established.



Kidney

Caution is advised in patients with moderate to severe kidney impairment; dosage adjustment may be necessary.



Liver

Caution is advised in patients with hepatic impairment; dosage adjustment may be necessary.

Consult your physician or pharmacist for complete information. Refer to the medication's package insert for detailed information.